- Home
- FDMT vs TGEN Comparison
FDMT vs TGEN Comparison
Compare FDMT & TGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- TGEN
- Stock Information
- Founded
- FDMT 2013
- TGEN 2000
- Country
- FDMT United States
- TGEN United States
- Employees
- FDMT N/A
- TGEN N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- TGEN
- Sector
- FDMT Health Care
- TGEN
- Exchange
- FDMT Nasdaq
- TGEN NYSE
- Market Cap
- FDMT 192.2M
- TGEN 171.8M
- IPO Year
- FDMT 2020
- TGEN N/A
- Fundamental
- Price
- FDMT $4.32
- TGEN $7.96
- Analyst Decision
- FDMT Buy
- TGEN
- Analyst Count
- FDMT 10
- TGEN 0
- Target Price
- FDMT $32.33
- TGEN N/A
- AVG Volume (30 Days)
- FDMT 418.9K
- TGEN 523.2K
- Earning Date
- FDMT 08-07-2025
- TGEN 08-11-2025
- Dividend Yield
- FDMT N/A
- TGEN N/A
- EPS Growth
- FDMT N/A
- TGEN N/A
- EPS
- FDMT N/A
- TGEN N/A
- Revenue
- FDMT $23,000.00
- TGEN $23,711,209.00
- Revenue This Year
- FDMT $13,048.65
- TGEN $155.81
- Revenue Next Year
- FDMT N/A
- TGEN $19.42
- P/E Ratio
- FDMT N/A
- TGEN N/A
- Revenue Growth
- FDMT N/A
- TGEN N/A
- 52 Week Low
- FDMT $2.24
- TGEN $0.65
- 52 Week High
- FDMT $28.93
- TGEN $9.38
- Technical
- Relative Strength Index (RSI)
- FDMT 57.43
- TGEN N/A
- Support Level
- FDMT $3.86
- TGEN N/A
- Resistance Level
- FDMT $4.48
- TGEN N/A
- Average True Range (ATR)
- FDMT 0.28
- TGEN 0.00
- MACD
- FDMT 0.01
- TGEN 0.00
- Stochastic Oscillator
- FDMT 89.81
- TGEN 0.00
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About TGEN TECOGEN INC
Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production. Products segment designs, manufactures, and sells industrial and commercial cogeneration systems. The services segment provides operations and maintenance services and turn-key installation for products under long-term service contracts. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to the customers under long-term energy sales agreements.